Erratum to: Interval colorectal cancers: What and why (Current Gastroenterology Reports (2014) 16, (375) DOI: 10.1007/s11894-014-0375-3);Interval colorectal cancers: What and why

Current Gastroenterology Reports

Volumn 16, Issue 3, 2014, Pages 387-

  Le Clercq, Chantal M C ^a   Sanduleanu, Silvia ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Detection; Endoscopy; Interval colorectal cancer; Management; Nonpolypoid colorectal neoplasm; Postcolonoscopy colorectal cancer; Serrated polyp

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SURGERY; COLONOSCOPY; COLORECTAL CANCER; DISEASE COURSE; HUMAN; NOMENCLATURE; NONPOLYPOID COLORECTAL NEOPLASM; POLYPECTOMY; POSTCOLONOSCOPY COLORECTAL CANCER; SESSILE SERRATED POLYP; COLORECTAL TUMOR; EARLY DIAGNOSIS; INCIDENCE; LABORATORY DIAGNOSIS; METHODOLOGY; MINIMAL RESIDUAL DISEASE; REVIEW; STANDARD;

COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; FALSE NEGATIVE REACTIONS; HUMANS; INCIDENCE; NEOPLASM, RESIDUAL;

EID: 84893690161     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-014-0387-z     Document Type: Erratum

References (70)

1. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-81. (Pubitemid 24015040)
2. Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology. 2004;127:1670-7. (Pubitemid 39575845)
3. Brenner H, Chang-Claude J, Seiler CM, et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154:22-30.
4. Lakoff J, Paszat LF, Saskin R, et al. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol. 2008;6:1117-21. quiz 1064.
5. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095-105.
6. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1-8.
7. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687-96.
8. Jacob BJ, Moineddin R, Sutradhar R, et al. Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc. 2012;76:355-64. quiz 1064.
9. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795-803.
10. Rex DK. Preventing colorectal cancer and cancer mortality with colonoscopy: what we know and what we don't know. Endoscopy. 2010;42:320-3.
11. Rabeneck L, Paszat LF. Circumstances in which colonoscopy misses cancer. Frontline Gastroenterol. 2010;1:52-8.
12. Farrar WD, Sawhney MS, Nelson DB, et al. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol. 2006;4:1259-64. (Pubitemid 44512220)
13. Matsuda T, Fujii T, Sano Y, et al. Five-year incidence of advanced neoplasia after initial colonoscopy in Japan: a multicenter retrospective cohort study. Jpn J Clin Oncol. 2009;39:435-42.
14. Singh H, Nugent Z, Demers AA, et al. Rate and predictors of early/missed colorectal cancers after colonoscopy in manitoba: a population-based study. Am J Gastroenterol. 2010;105:2588-96.
15. Strock P, Mossong J, Scheiden R, et al. Colorectal cancer incidence is low in patients following a colonoscopy. Dig Liver Dis. 2011;43:899-904.
16. Cooper GS, Xu F, Barnholtz Sloan JS, et al. Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer. 2012;118:3044-52.
17. Brenner H, Chang-Claude J, Seiler CM, et al. Interval cancers after negative colonoscopy: population-based case-control study. Gut. 2012;61:1576-82.
18. Robertson DJ, Lieberman DA, Winawer SJ, et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut 2013.
19. le Clercq CMC, Bouwens MWE, Rondagh EJA, et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut 2013.
20. Erichsen R, Baron JA, Stoffel EM, et al. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol. 2013;108:1332-40.
21. Samadder NJ, Curtin K, Tuohy T, et al. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology 2014.
22. Rex DK, Bond JH, Feld AD. Medical-legal risks of incident cancers after clearing colonoscopy. Am J Gastroenterol. 2001;96:952-7. (Pubitemid 32319122)
23. Sanduleanu S, Masclee AM, Meijer GA. Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol. 2012;9:550-4.
24. Bressler B, Paszat LF, Chen Z, et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132:96-102. (Pubitemid 46108740)
25. Singh H, Nugent Z, Demers AA, et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology. 2010;139:1128-37.
26. Baxter NN, Warren JL, Barrett MJ, et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol. 2012;30:2664-9.
27. Ferrandez A, Navarro M, Diez M, et al. Risk factors for advanced lesions undetected at prior colonoscopy: not always poor preparation. Endoscopy. 2010;42:1071-6.
28. Huang Y, Gong W, Su B, et al. Risk and cause of interval colorectal cancer after colonoscopic polypectomy. Digestion. 2012;86:148-54.
29. Horiuchi A, Nakayama Y, Kajiyama M, et al. Invasive colorectal cancer within 5 years of negative colonoscopy in a Japanese population. Colorectal Dis. 2012;14:1090-4.
30. Brenner H, Altenhofen L, Katalinic A, et al. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol. 2011;174:1140-6.
31. Shah HA, Paszat LF, Saskin R, et al. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology. 2007;132:2297-303. (Pubitemid 46890860)
32. Leung K, Pinsky P, Laiyemo AO, et al. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc. 2010;71:111-7.
33. Pabby A, Schoen RE, Weissfeld JL, et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc. 2005;61:385-91. (Pubitemid 40349030)
34. Wyse JM, Joseph L, Barkun AN, et al. Accuracy of administrative claims data for polypectomy. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2011;183:E743-7.
35. Baxter NN, Sutradhar R, Forbes SS, et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011;140:65-72.
36. Ausk K, Dominitz JA. Association of adenoma detection rate with the risk of interval cancer. Gastroenterology. 2011;140:724-6.
37. Haug U, Regula J. Interval cancer: nightmare of colonoscopists. Gut 2013.
38. Haseman JH, Lemmel GT, Rahmani EY, et al. Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc. 1997;45:451-5. (Pubitemid 27424393)
39. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Gastrointest Endosc. 2012;75:612-20.
40. Dominitz JA, Robertson DJ. Interval cancers: learning from the past as we build for the future. Am J Gastroenterol. 2013;108:1341-3.
41. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005;129:34-41. (Pubitemid 41002040)
42. Gorski TF, Rosen L, Riether R, et al. Colorectal cancer after surveillance colonoscopy: false-negative examination or fast growth? Dis Colon Rectum. 1999;42:877-80. (Pubitemid 29328457)
43. Pohl H, Robertson DJ. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol. 2010;8:858-64.
44. Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006;355:2533-41. (Pubitemid 44917501)
45. Rondagh EJ, Masclee AA, van der Valk ME, et al. Nonpolypoid colorectal neoplasms: gender differences in prevalence and malignant potential. Scand J Gastroenterol. 2012;47:80-8.
46. Rondagh EJ, Bouwens MW, Riedl RG, et al. Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopy in cancer prevention. Gastrointest Endosc. 2012;75:1218-25.
47. Chiu HM, Lin JT, Lee YC, et al. Different bowel preparation schedule leads to different diagnostic yield of proximal and nonpolypoid colorectal neoplasm at screening colonoscopy in average-risk population. Dis Colon Rectum. 2011;54:1570-7.
48. Sanduleanu S, Rondagh EJ, Masclee AA. Development of expertise in the detection and classification of non-polypoid colorectal neoplasia: Experience-based data at an academic GI unit. Gastrointest Endosc Clin N Am. 2010;20:449-60.
49. Soetikno RM, Kaltenbach T, Rouse RV, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008;299:1027-35. (Pubitemid 351347059)
50. Miller GE. The assessment of clinical skills/competence/performance. Acad Med. 1990;65:S63-7. (Pubitemid 20333148)
51. Gupta S, Balasubramanian BA, Fu T, et al. Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening. Clin Gastroenterol Hepatol. 2012;10:1395-401. quiz 1064.
52. Bouwens MWE, Kaltenbach T, Soetikno R, et al. Flat, hyperplastic, and sessile serrated polyps. Techniques in Gastrointestinal Endoscopy. 2013;15:69-76.
53. Rondagh EJ, Masclee AA, Bouwens MW, et al. Endoscopic red flags for the detection of high-risk serrated polyps: an observational study. Endoscopy. 2011;43:1052-8.
54. Sweetser S, Smyrk TC, Sugumar A. Serrated polyps: critical precursors to colorectal cancer. Expert Rev Gastroenterol Hepatol. 2011;5:627-35.
55. Hetzel JT, Huang CS, Coukos JA, et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol. 2010;105:2656-64.
56. Bouwens MW, Winkens B, Rondagh EJ, et al. Simple clinical risk score identifies patients with serrated polyps in routine practice. Cancer Prev Res. 2013;6:855-63.
57. Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144:74-80. quiz 1064.
58. Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010;105:1189-95.
59. Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in interval colon cancers. Gastroenterology. 2006;131:1700-5. (Pubitemid 44958526)
60. Shaukat A, Arain M, Thaygarajan B, et al. Is BRAF mutation associated with interval colorectal cancers? Dig Dis Sci. 2010;55:2352-6.
61. Shaukat A, Arain M, Anway R, et al. Is KRAS mutation associated with interval colorectal cancers? Dig Dis Sci. 2012;57:913-7.
62. le Clercq C, Riedl R, Bouwens M, et al. Sa1689 Microsatellite Instability, BRAF and KRAS Mutation in Postcolonoscopy Cancers: An Explorative Study. Gastroenterology. 2013;144:S-283.
63. Voorham QJ, Rondagh EJ, Knol DL, et al. Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis. Am J Gastroenterol. 2013;108:1042-56.
64. Moss A, Bourke MJ, Williams SJ, et al. Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia. Gastroenterology. 2011;140:1909-18.
65. Voorham QJ, Carvalho B, Spiertz AJ, et al. Chromosome 5q loss in colorectal flat adenomas. Clin Cancer Res. 2012;18:4560-9.
66. Burnett-Hartman AN, Newcomb PA, Potter JD, et al. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res. 2013;73:2863-72.
67. Kahi CJ, Imperiale TF, Juliar BE, et al. Effect of screening colonoscopy on colorectal cancer incidence andmortality. Clin Gastroenterol Hepatol. 2009;7:770-5. quiz 1064.
68. Imperiale TF, Glowinski EA, Lin-Cooper C, et al. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med. 2008;359:1218-24.
69. Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007;133:1077-85. (Pubitemid 47494453)
70. Leaper M, Johnston MJ, Barclay M, et al. Reasons for failure to diagnose colorectal carcinoma at colonoscopy. Endoscopy. 2004;36:499-503. (Pubitemid 38811617)